NXU INC (NXU)

US62956D2045 - Common Stock

0.2238  0 (-0.31%)

After market: 0.2219 0 (-0.85%)

Fundamental Rating

2

Taking everything into account, NXU scores 2 out of 10 in our fundamental rating. NXU was compared to 122 industry peers in the Specialty Retail industry. NXU may be in some trouble as it scores bad on both profitability and health. NXU does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

In the past year NXU has reported negative net income.
In the past year NXU has reported a negative cash flow from operations.
In the past 5 years NXU always reported negative net income.
In the past 5 years NXU always reported negative operating cash flow.

1.2 Ratios

NXU's Return On Assets of -152.95% is on the low side compared to the rest of the industry. NXU is outperformed by 98.35% of its industry peers.
NXU's Return On Equity of -304.31% is on the low side compared to the rest of the industry. NXU is outperformed by 81.82% of its industry peers.
Industry RankSector Rank
ROA -152.95%
ROE -304.31%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 78.03%, NXU belongs to the best of the industry, outperforming 98.35% of the companies in the same industry.
NXU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

NXU does not have a ROIC to compare to the WACC, probably because it is not profitable.
NXU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

NXU has an Altman-Z score of -32.34. This is a bad value and indicates that NXU is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -32.34, NXU is not doing good in the industry: 95.04% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.01 indicates that NXU is not too dependend on debt financing.
NXU has a Debt to Equity ratio of 0.01. This is in the better half of the industry: NXU outperforms 75.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -32.34
ROIC/WACCN/A
WACC6.43%

2.3 Liquidity

NXU has a Current Ratio of 0.73. This is a bad value and indicates that NXU is not financially healthy enough and could expect problems in meeting its short term obligations.
NXU has a worse Current ratio (0.73) than 90.91% of its industry peers.
NXU has a Quick Ratio of 0.73. This is a bad value and indicates that NXU is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.73, NXU is in the better half of the industry, outperforming 65.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.73

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 82.16% over the past year.
Looking at the last year, NXU shows a very strong growth in Revenue. The Revenue has grown by 230.00%.
EPS 1Y (TTM)82.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.73%
Revenue 1Y (TTM)230%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-94.87%

3.2 Future

NXU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.36% yearly.
Based on estimates for the next years, NXU will show a very negative growth in Revenue. The Revenue will decrease by -41.42% on average per year.
EPS Next Y99.29%
EPS Next 2Y41.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

NXU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

NXU's earnings are expected to grow with 41.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.36%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for NXU!.
Industry RankSector Rank
Dividend Yield N/A

NXU INC

NASDAQ:NXU (12/20/2024, 8:00:01 PM)

After market: 0.2219 0 (-0.85%)

0.2238

0 (-0.31%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)N/A N/A
Inst Owners0.93%
Inst Owner Change78.16%
Ins Owners2.99%
Ins Owner Change0.09%
Market Cap3.61M
Analysts45
Price Target114.75 (51173.46%)
Short Float %2.2%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24.87%
Min EPS beat(2)-38.61%
Max EPS beat(2)-11.13%
EPS beat(4)1
Avg EPS beat(4)-287.55%
Min EPS beat(4)-1104.62%
Max EPS beat(4)4.15%
EPS beat(8)3
Avg EPS beat(8)-143.77%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)42%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.1
P/FCF N/A
P/OCF N/A
P/B 0.54
P/tB 0.54
EV/EBITDA N/A
EPS(TTM)-93.13
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)-0.9
OCFYN/A
SpS0.02
BVpS0.41
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -152.95%
ROE -304.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.03%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 255.78%
Cap/Sales 581.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.73
Altman-Z -32.34
F-Score5
WACC6.43%
ROIC/WACCN/A
Cap/Depr(3y)659.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.73%
EPS Next Y99.29%
EPS Next 2Y41.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)230%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-94.87%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year74.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.84%
OCF growth 3YN/A
OCF growth 5YN/A